RxDoctor Payments Data

Casey Shehan, NP

Nurse Practitioner · Hendersonville, NCNPI 1730895376

Payments from drug & device makers

$615in general payments, 2019–2025

Across 20 payments — averaging $30.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abiomed$229
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$142
  • E.r. Squibb & Sons, L.L.C.$80
  • Johnson & Johnson$60
  • Bayer$50
  • Philips North America LLC$39
  • plus $15 from 1 others

What the payments were for

  • Food & beverage$615100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$615 in reported general payments places this provider in the 70th percentile of 4,393 nurse practitioner providers in North Carolina.

See all nurse practitioner providers in North Carolina

Medicare billing

Part B allowed, 2024
$70,478
Medicare patients
535
Services billed
707

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban229$217,365
XareltoRivaroxaban112$123,645
EntrestoSacubitril/Valsartan73$77,861
JardianceEmpagliflozin71$45,219
Repatha SureclickEvolocumab15$15,725
Ranolazine ErRanolazine54$4,278
Dabigatran EtexilateDabigatran Etexilate Mesylate15$4,070
Metoprolol Succinate229$2,805
Losartan Potassium157$1,883
Flecainide Acetate46$1,504
Isosorbide Mononitrate ErIsosorbide Mononitrate121$1,195
Furosemide212$1,129
Midodrine Hcl25$1,088
Atorvastatin Calcium97$1,077
Potassium Chloride63$1,049

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$60$123,645112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,393 nurse practitioner providers in North Carolina.

Other nurse practitioner in Hendersonville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →